Company profile: Huinno
1.1 - Company Overview
Company description
- Provider of AI-enabled wearable cardiac monitoring solutions: MEMO Solution and MEMO Patch 2 for 14-day continuous ECG monitoring; MEMO Care, a web platform for patient management with cloud ECG storage/analysis; MEMO Link, a gateway transmitting real-time biometric data to avoid network disruptions in emergencies; and MEMO Q for remote patient monitoring and ECG/biometric diagnostics, helping prevent arrhythmia, stroke, and hypertension.
Products and services
- MEMO Care: Web-based platform managing patient data from registration to report generation, delivering cloud-based ECG data storage and analysis
- MEMO Patch 2: Lightweight wearable ECG device designed for comfort, enabling continuous monitoring up to 14 days with integrated electrodes
- MEMO Solution: AI-based wearable ECG monitoring system that extends monitoring duration up to 14 days, enhancing arrhythmia detection accuracy through AI-based analysis
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Huinno
FoxHollow Technologies
HQ: United States
Website
- Description: Provider of medical devices for the treatment of peripheral artery disease (PAD) and other cardiovascular disease, including the SilverHawk Plaque Excision System, a minimally-invasive catheter system that removes plaque to reopen narrowed or blocked arteries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FoxHollow Technologies company profile →
Angiodroid
HQ: Italy
Website
- Description: Provider of automatic carbon dioxide angiography solutions for hemodynamics, vascular surgery, and interventional radiology, including Angiodroid The CO2 Injector for peripheral diagnostic and interventional procedures, the Angiodroid Easy Kit disposable accessories, ANGIOPULSE counterpulsation weaning console, and the ACDA Academy offering training, articles, conferences, and live case streaming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Angiodroid company profile →
Third Pole
HQ: United States
Website
- Description: Provider of electric nitric oxide generation and delivery solutions for hospital, ambulatory, and home use. Products include eNOfit, a portable inhaled nitric oxide device for on-the-go treatment of severe COPD and ILD; eNOcare, an FDA-designated breakthrough hospital device for critical life-sustaining therapies; and on-demand iNO generation technology from air for bedside and portable therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Third Pole company profile →
CardioNexion Health
HQ: France
Website
- Description: Provider of custom medical monitoring solutions for cardiovascular diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioNexion Health company profile →
Concept Medical
HQ: United States
Website
- Description: Provider of medical devices for treating coronary and peripheral artery disease, including a polymer nano-carrier eluting coronary stent system, sirolimus-coated balloon catheters for coronary disease, a sirolimus coronary eluting stent for diabetic patients, and sirolimus drug-coated balloons for arteriovenous fistula and peripheral arteries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Concept Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Huinno
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Huinno
2.2 - Growth funds investing in similar companies to Huinno
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Huinno
4.2 - Public trading comparable groups for Huinno
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →